Details for Patent: 9,402,874
✉ Email this page to a colleague
Summary for Patent: 9,402,874
Title: | Low frequency glatiramer acetate therapy |
Abstract: | A method of alleviating a symptom of relapsing-remitting multiple sclerosis in a human patient suffering from relapsing-remitting multiple sclerosis or a patient who has experienced a first clinical episode and is determined to be at high risk of developing clinically definite multiple sclerosis comprising administering to the human patient three subcutaneous injections of a therapeutically effective dose of glatiramer acetate over a period of seven days with at least one day between every subcutaneous injection so as to thereby alleviate the symptom of the patient. |
Inventor(s): | Klinger; Ety (Tel Aviv, IL) |
Assignee: | YEDA RESEARCH & DEVELOPMENT CO., LTD. (Rehovot, IL) |
Application Number: | 14/673,257 |
Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 9,402,874 |
Patent Claim Types: see list of patent claims | Use; Delivery; Formulation; |
Drugs Protected by US Patent 9,402,874
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,402,874
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
Argentina | 077896 | ⤷ Try a Trial | |||
Argentina | 099078 | ⤷ Try a Trial | |||
Argentina | 121549 | ⤷ Try a Trial | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |